{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:52:05Z","timestamp":1783633925711,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T00:00:00Z","timestamp":1132099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T00:00:00Z","timestamp":1132099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Dehydroepiandrosterone (DHEA), an adrenal 17-ketosteroid, is a precursor of testosterone and 17\u03b2-estradiol. Studies have shown that DHEA inhibits carcinogenesis in mammary gland and prostate as well as other organs, a process that is not hormone dependent. Little is known about the molecular mechanisms of DHEA-mediated inhibition of the neoplastic process. Here we examine whether DHEA and its analog DHEA 8354 can suppress the progression of hyperplastic and premalignant (carcinoma <jats:italic>in situ<\/jats:italic>) lesions in mammary gland toward malignant tumors and the cellular mechanisms involved.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Rats were treated with <jats:italic>N<\/jats:italic>-nitroso-<jats:italic>N<\/jats:italic>-methylurea and allowed to develop mammary hyperplastic and premalignant lesions with a maximum frequency 6 weeks after carcinogen administration. The animals were then given DHEA or DHEA 8354 in the diet at 125 or 1,000 mg\/kg diet for 6 weeks. The effect of these agents on induction of apoptosis, senescence, cell proliferation, tumor burden and various effectors of cellular signaling were determined.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Both agents induced a dose-dependent decrease in tumor multiplicity and in tumor burden. In addition they induced a senescent phenotype in tumor cells, inhibited cell proliferation and increased the number of apoptotic cells. The DHEA-induced cellular effects were associated with increased expression of p16 and p21, but not p53 expression, implicating a p53-independent mechanism in their action.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>We provide evidence that DHEA and DHEA 8354 can suppress mammary carcinogenesis by altering various cellular functions, inducing cellular senescence, in tumor cells with the potential involvement of p16 and p21 in mediating these effects.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1350","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T19:13:57Z","timestamp":1132168437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism"],"prefix":"10.1186","volume":"7","author":[{"given":"Anne","family":"Shilkaitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasu","family":"Punj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Lubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Christov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,16]]},"reference":[{"key":"1329_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1749-6632.1995.tb17381.x","volume":"774","author":"A Schwartz","year":"1995","unstructured":"Schwartz A, Pashko L: Mechanism of cancer prevention action of DHEA. Ann NY Acad Sci. 1995, 774: 180-186.","journal-title":"Ann NY Acad Sci"},{"key":"1329_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0140-6736(71)90113-9","volume":"2","author":"RD Bullbrock","year":"1971","unstructured":"Bullbrock RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 1971, 2: 395-398. 10.1016\/S0140-6736(71)90113-9.","journal-title":"Lancet"},{"key":"1329_CR3","first-page":"177","volume":"6","author":"JF Dorgan","year":"1997","unstructured":"Dorgan JF, Stanczyk FZ, Longscope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L: Relationship of serum dehydroepiandrosterone (DHEA) dehydroepiandrosterone sulfate and 5-androstene-\u03b2, 17-\u03b2-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomark Prev. 1997, 6: 177-181.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1329_CR4","first-page":"481","volume":"51","author":"TA Ratko","year":"1991","unstructured":"Ratko TA, Detrisac CJ, Mehta RG, Kelloff GJ, Moon RC: Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepindrosterone or a fluorinated analogue dehydroepiandrosterone. Cancer Res. 1991, 51: 481-486.","journal-title":"Cancer Res"},{"key":"1329_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00665681","volume":"29","author":"S Li","year":"1994","unstructured":"Li S, Yan XX, Belanger A, Labrie F: Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by DMBA in the rat. Breast Cancer Res Treat. 1994, 29: 203-217. 10.1007\/BF00665681.","journal-title":"Breast Cancer Res Treat"},{"key":"1329_CR6","first-page":"1724","volume":"56","author":"DL McCormic","year":"1996","unstructured":"McCormic DL, Rao KVN, Johnson WD, Bowman-Gram TA, Steele V, Lubet RA, Kelloff G: Exceptional chemopreventive activity of low-dose DHEA in the rat mammary gland. Cancer Res. 1996, 56: 1724-1726.","journal-title":"Cancer Res"},{"key":"1329_CR7","first-page":"921","volume":"58","author":"RL Lubet","year":"1998","unstructured":"Lubet RL, Gordon GB, Prough RA, Lei XD, You M, Wang Y, Grubbs CJ, Steele VE, Kelloff GJ, Thomas KF, et al: Modulation of methylnitrosourea-induced breast cancer in Sprague-Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effect of limited exosure, effects on peroxysomal enzymes, and lack of effects on levels of Ha-Ras mutations. Cancer Res. 1998, 58: 921-926.","journal-title":"Cancer Res"},{"key":"1329_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/A:1005788326534","volume":"43","author":"T Kohama","year":"1997","unstructured":"Kohama T, Terada S, Suzuki N, Inue M: Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7,12-dimethylbenz(a)anthracene (DMBA) in hyperprolactinemic female rats. Breast Cancer Res Treat. 1997, 43: 105-115. 10.1023\/A:1005788326534.","journal-title":"Breast Cancer Res Treat"},{"key":"1329_CR9","first-page":"7449","volume":"61","author":"JE Green","year":"2001","unstructured":"Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R: 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)\/SV40 T\/t-antigen transgenic mice. Cancer Res. 2001, 61: 7449-7455.","journal-title":"Cancer Res"},{"key":"1329_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/jnci\/90.10.772","volume":"90","author":"S Couillard","year":"1998","unstructured":"Couillard S, Labrie C, Belanger A, Candas B, Pouliot F, Labrie F: Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR75-1 breast cancer xenografts. J Natl Cancer Inst. 1998, 90: 772-778. 10.1093\/jnci\/90.10.772.","journal-title":"J Natl Cancer Inst"},{"key":"1329_CR11","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Xinhua L, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linkens M, Rube JI, Pereira-Smith O, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995, 92: 9363-9367.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1329_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0959-8049(02)00497-5","volume":"39","author":"K Christov","year":"2003","unstructured":"Christov K, Kim E, Shilkaitis A, Green A, Steele V, Lubet R: Chemopreventive agents induce senescence-like phenotype in mammary tumors of rats. Eur J Cancer. 2003, 39: 230-239. 10.1016\/S0959-8049(02)00497-5.","journal-title":"Eur J Cancer"},{"key":"1329_CR13","first-page":"3761","volume":"59","author":"DC Chang","year":"1999","unstructured":"Chang DC, Broudy E, Dokmanovic D, Zhu H, Ruth A, Xang Y, Kande ES, Lausch E, Christov K, Roninson IB: A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 1999, 59: 3761-3767.","journal-title":"Cancer Res"},{"key":"1329_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0959-8049(96)00058-5","volume":"33","author":"J Campisi","year":"1997","unstructured":"Campisi J: The biology of replicative senescence. Eur J Cancer. 1997, 33: 703-709. 10.1016\/S0959-8049(96)00058-5.","journal-title":"Eur J Cancer"},{"key":"1329_CR15","doi-asserted-by":"publisher","first-page":"9648","DOI":"10.1073\/pnas.94.18.9648","volume":"94","author":"MM Sugrue","year":"1997","unstructured":"Sugrue MM, Shin DY, Lee SW, Aaronson SA: Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA. 1997, 94: 9648-9653. 10.1073\/pnas.94.18.9648.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1329_CR16","first-page":"1597","volume":"24","author":"J Duan","year":"2004","unstructured":"Duan J, Chen Z, Liu P, Zhang Z, Tong T: Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells. Int J Oncol. 2004, 24: 1597-1605.","journal-title":"Int J Oncol"},{"key":"1329_CR17","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/sj.onc.1201446","volume":"15","author":"HJ Xu","year":"1997","unstructured":"Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J, Hu SX: Re expression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 1997, 15: 2589-2596. 10.1038\/sj.onc.1201446.","journal-title":"Oncogene"},{"key":"1329_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jnci\/93.1.39","volume":"93","author":"BS Herbert","year":"2001","unstructured":"Herbert BS, Wright AC, Passons CM, Wright WE, Ali IU, Kopelovich L, Shay JW: Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst. 2001, 93: 39-45. 10.1093\/jnci\/93.1.39.","journal-title":"J Natl Cancer Inst"},{"key":"1329_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1021804121171","volume":"77","author":"K Christov","year":"2003","unstructured":"Christov K, Ikui A, Shilkaitis A, Green A, Yao R, You M, Grubbs C, Steele V, Lubet R, Weinstein IB: Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors. Breast Cancer Res Treat. 2003, 77: 253-264. 10.1023\/A:1021804121171.","journal-title":"Breast Cancer Res Treat"},{"key":"1329_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/A:1006384026252","volume":"60","author":"K Christov","year":"2000","unstructured":"Christov K, Shilkaitis A, Green A, Mehta RG, Grubbs C, Kelloff G, Lubet R: Cellular responses of mammary tumors to aromatase inhibitors, effects of Vorozole. Breast Cancer Res Treat. 2000, 60: 117-128. 10.1023\/A:1006384026252.","journal-title":"Breast Cancer Res Treat"},{"key":"1329_CR21","first-page":"753","volume-title":"Cytometry","author":"LL Vindelow","year":"1990","unstructured":"Vindelow LL, Christiansen IJ: A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry. 1990, 753-770. 10.1002\/cyto.990110702. ch. 11"},{"key":"1329_CR22","volume-title":"Statistical Methods","author":"GJW Snedecer","year":"1998","unstructured":"Snedecer GJW, Cochran WG: Statistical Methods. 1998, Ames, IA: Iowa State University Press, 11: 8","edition":"8"},{"key":"1329_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/carcin\/20.8.1535","volume":"20","author":"A Green","year":"1999","unstructured":"Green A, Shilkaitis A, Christov K: 4-HPR selectively suppresses the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary carcinogenesis. Carcinogenesis. 1999, 20: 1535-1540. 10.1093\/carcin\/20.8.1535.","journal-title":"Carcinogenesis"},{"key":"1329_CR24","first-page":"1876","volume":"62","author":"RH te Poele","year":"2002","unstructured":"te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP: DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002, 62: 1876-1883.","journal-title":"Cancer Res"},{"key":"1329_CR25","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1073\/pnas.97.8.4291","volume":"97","author":"BD Chang","year":"2000","unstructured":"Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinchenko TV, Roninson I: Effects of p21waf1\/Cip1\/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA. 2000, 97: 4291-4296. 10.1073\/pnas.97.8.4291.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1329_CR26","first-page":"2677","volume":"40","author":"J Russo","year":"1980","unstructured":"Russo J, Russo IH: Influence of differentiation and cell kinetics on the susceptibility of rat mammary gland to carcinogenesis. Cancer Res. 1980, 40: 2677-2687.","journal-title":"Cancer Res"},{"key":"1329_CR27","first-page":"3084","volume":"59","author":"KV Rao","year":"1999","unstructured":"Rao KV, Johnson WD, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, McCormick DL: Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res. 1999, 59: 3084-3089.","journal-title":"Cancer Res"},{"key":"1329_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/frne.2001.0216","volume":"22","author":"F Labrie","year":"2001","unstructured":"Labrie F, Luu-The V, Labrie C, Simard J: DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocr inol. 2001, 22: 185-212. 10.1006\/frne.2001.0216.","journal-title":"Front Neuroendocr inol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1350\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:04:02Z","timestamp":1728385442000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,16]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1186\/bcr1350","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,16]]},"assertion":[{"value":"24 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R1132"}}